close
close

HCA Healthcare (NYSE:HCA) price target raised to $376.00 by Barclays analysts

HCA Healthcare (NYSE:HCA) price target raised to 6.00 by Barclays analysts

HCA Healthcare (NYSE:HCA – Free Report) Barclays Inc. raised its price target from $367.00 to $376.00 in a report published Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other research analysts have also recently commented on the company. Cantor Fitzgerald reiterated an overweight rating and gave the stock a $335.00 price target in a report on Tuesday. Wells Fargo & Company raised their price target on HCA Healthcare from $303.00 to $315.00 and gave the stock an equal weight rating in a research note on Thursday, March 28th. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $327.00 to $332.00 and gave the stock a neutral rating in a research note on Thursday, May 30th. Oppenheimer raised their price target on HCA Healthcare from $330.00 to $345.00 and gave the stock an outperform rating in a research note on Monday, April 29th. Finally, Baird RW raised HCA Healthcare to a strong-buy rating in a research note on Thursday, May 30th. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of Moderate Buy and an average price target of $327.06.

View our latest analysis on HCA Healthcare

HCA Healthcare Price Development

HCA shares opened at $315.35 on Wednesday. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16, and a quick ratio of 1.02. The company has a 50-day simple moving average of $327.08 and a 200-day simple moving average of $319.68. The company has a market cap of $82.59 billion, a price-to-earnings ratio of 15.72, a price-to-earnings growth ratio of 1.43, and a beta of 1.68. HCA Healthcare has a 1-year low of $215.96 and a 1-year high of $344.20.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, April 26. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. In the year-ago period, the company posted $4.93 EPS. The company’s quarterly revenue increased 11.2% year over year. Equity analysts expect HCA Healthcare to post $20.97 EPS for the current fiscal year.

HCA Healthcare announces dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were paid a dividend of $0.66. This represents an annualized dividend of $2.64 and a yield of 0.84%. The ex-dividend date was Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Insiders place their bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. ​​The sale was disclosed in a filing with the SEC, which is available on the SEC website. In other news, SVP Jeffrey E. Cohen sold 1,650 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $313.00, for a total transaction of $516,450.00. Following the completion of the sale, the senior vice president now owns 5,185 shares of the company’s stock, valued at $1,622,905. The sale was disclosed in a legal filing with the Securities & Exchange Commission, available at this link. Also, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction dated Monday, May 6. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the sale, the executive vice president now owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. ​​The disclosure for this sale can be found here. In the last 90 days, insiders have sold 12,397 shares of the company’s stock for $3,921,929. 1.70% of the shares are currently owned by insiders.

Institutional investors weigh in on HCA Healthcare

Several hedge funds have recently modified their positions in the company. Parkside Financial Bank & Trust increased its position in HCA Healthcare by 8.2% in the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock worth $125,000 after purchasing an additional 35 shares during the period. FinTrust Capital Advisors LLC increased its position in HCA Healthcare by 26.7% in the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after purchasing an additional 35 shares during the period. Financial Counselors Inc. increased its position in HCA Healthcare by 1.4% in the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock worth $881,000 after purchasing an additional 36 shares during the period. Ballentine Partners LLC increased its position in HCA Healthcare by 1.0% in the first quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock worth $1,294,000 after purchasing an additional 38 shares during the period. Finally, Wedmont Private Capital increased its position in HCA Healthcare by 1.6% in the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock worth $711,000 after purchasing an additional 39 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Company Profile HCA Healthcare

(Get free report)

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare facilities in the United States. It operates general and acute care hospitals that provide medical and surgical services, including inpatient, intensive care, cardiac care, diagnostic and emergency care; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy.

Read further

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Get news and reviews for HCA Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings on HCA Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.